Cargando…
Recent advances of exosomes in age-related macular degeneration
Exosomes are 30–150 nm extracellular vesicles that are secreted by almost all types of cells. Exosomes contain a variety of biologically active substances, such as proteins, nucleic acids, and lipids, and are important in the intercellular communication of biological mediators involved in nerve inju...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272348/ https://www.ncbi.nlm.nih.gov/pubmed/37332352 http://dx.doi.org/10.3389/fphar.2023.1204351 |
_version_ | 1785059473083072512 |
---|---|
author | Gu, Feng Jiang, Jiyu Sun, Peng |
author_facet | Gu, Feng Jiang, Jiyu Sun, Peng |
author_sort | Gu, Feng |
collection | PubMed |
description | Exosomes are 30–150 nm extracellular vesicles that are secreted by almost all types of cells. Exosomes contain a variety of biologically active substances, such as proteins, nucleic acids, and lipids, and are important in the intercellular communication of biological mediators involved in nerve injury and repair, vascular regeneration, immune response, fibrosis formation, and many other pathophysiological processes. Although it has been extensively studied in the field of cancer, the exploration of ocular diseases has only just begun. Here, we discuss the latest developments in exosomes for age-related macular degeneration (AMD), including the pathogenesis of exosomes in age-related macular degeneration, their potential as diagnostic markers, and therapeutic vectors of the disease. Finally, the study of exosomes in age-related macular degeneration is still relatively few, and more detailed basic research and clinical trials are needed to verify its application in treatment and diagnosis, so as to adopt more personalized diagnosis and treatment strategies to stop the progression of age-related macular degeneration. |
format | Online Article Text |
id | pubmed-10272348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102723482023-06-17 Recent advances of exosomes in age-related macular degeneration Gu, Feng Jiang, Jiyu Sun, Peng Front Pharmacol Pharmacology Exosomes are 30–150 nm extracellular vesicles that are secreted by almost all types of cells. Exosomes contain a variety of biologically active substances, such as proteins, nucleic acids, and lipids, and are important in the intercellular communication of biological mediators involved in nerve injury and repair, vascular regeneration, immune response, fibrosis formation, and many other pathophysiological processes. Although it has been extensively studied in the field of cancer, the exploration of ocular diseases has only just begun. Here, we discuss the latest developments in exosomes for age-related macular degeneration (AMD), including the pathogenesis of exosomes in age-related macular degeneration, their potential as diagnostic markers, and therapeutic vectors of the disease. Finally, the study of exosomes in age-related macular degeneration is still relatively few, and more detailed basic research and clinical trials are needed to verify its application in treatment and diagnosis, so as to adopt more personalized diagnosis and treatment strategies to stop the progression of age-related macular degeneration. Frontiers Media S.A. 2023-06-02 /pmc/articles/PMC10272348/ /pubmed/37332352 http://dx.doi.org/10.3389/fphar.2023.1204351 Text en Copyright © 2023 Gu, Jiang and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Gu, Feng Jiang, Jiyu Sun, Peng Recent advances of exosomes in age-related macular degeneration |
title | Recent advances of exosomes in age-related macular degeneration |
title_full | Recent advances of exosomes in age-related macular degeneration |
title_fullStr | Recent advances of exosomes in age-related macular degeneration |
title_full_unstemmed | Recent advances of exosomes in age-related macular degeneration |
title_short | Recent advances of exosomes in age-related macular degeneration |
title_sort | recent advances of exosomes in age-related macular degeneration |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272348/ https://www.ncbi.nlm.nih.gov/pubmed/37332352 http://dx.doi.org/10.3389/fphar.2023.1204351 |
work_keys_str_mv | AT gufeng recentadvancesofexosomesinagerelatedmaculardegeneration AT jiangjiyu recentadvancesofexosomesinagerelatedmaculardegeneration AT sunpeng recentadvancesofexosomesinagerelatedmaculardegeneration |